Vaccines in the Prevention of Viral Pneumonia.
Pneumonia is of great global public health importance. Viral infections play both direct and indirect parts in its cause across the globe. Influenza is a leading cause of viral pneumonia in both children and adults, and respiratory syncytial virus is increasingly recognized as causing disease at both extremes of age. Vaccination offers the best prospect for prevention but current influenza vaccines do not provide universal and durable protection, and require yearly reformulation. In the future, it is hoped that influenza vaccines will give better and universal protection, and that new vaccines can be found for other causes of viral pneumonia.
Respiratory Sciences, National Heart and Lung Institute, Imperial College London (St Mary's Campus), Norfolk Place, Paddington, London W2 1PG, UK.
Clementine S
CS
Fraser
Respiratory Sciences, National Heart and Lung Institute, Imperial College London (St Mary's Campus), Norfolk Place, Paddington, London W2 1PG, UK.
Akhilesh
A
Jha
Respiratory Sciences, National Heart and Lung Institute, Imperial College London (St Mary's Campus), Norfolk Place, Paddington, London W2 1PG, UK. Electronic address: p.openshaw@imperial.ac.uk.
Peter J M
PJ
Openshaw
D006801:Humans; D011024:Pneumonia, Viral / Q000188:drug therapy* / Q000821:virology; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy*; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*
D014612:Vaccines
Adenovirus; Influenza; Lower respiratory tract infection (LRTI); Parainfluenza; Respiratory syncytial virus (RSV); Vaccination; Viral pneumonia